ECS Botanics HoldingsASX:ECS Days Inventory is 377.71 as of Dec. 2025, which is 11% below its 10-year median of 422.51. The stock has 9 warning signs investors should review. Among 916 Drug Manufacturers companies, ECS Botanics Holdings ranks worse than 96.4% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
ECS Botanics Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.48.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ECS Botanics Holdings's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 1.20.
ECS Botanics Holdings (ASX:ECS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
ECS Botanics Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ECS Botanics Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
ECS Botanics Holdings Days Inventory Related Terms
ECS Botanics Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for ECS Botanics Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, ECS Botanics Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ECS Botanics Holdings Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ECS Botanics Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where ECS Botanics Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ECS Botanics Holdings (ASX:ECS) has a Days Inventory of 377.71 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ECS Botanics Holdings and its competitors. This is 11% below median its historical median of 422.51. Over the past decade, ECS Botanics Holdings' Days Inventory has ranged from 275.12 to 614.10. According to the industry distribution chart, ECS Botanics Holdings ranks #883 out of 916 companies in the Drug Manufacturers industry, placing it in the top 96.4%.
Is ECS Botanics Holdings' Days Inventory too high?
ECS Botanics Holdings' current Days Inventory of 377.71 is 11% below median its 10-year median of 422.51. Over the past 10 years, this metric has ranged from a low of 275.12 to a high of 614.10. The Drug Manufacturers industry median Days Inventory is 164.43. ECS Botanics Holdings' value of 377.71 is 129.7% above this industry median. Based on the distribution chart, ECS Botanics Holdings ranks #883 out of 916 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does ECS Botanics Holdings' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, ECS Botanics Holdings ranks #883 out of 916 companies for Days Inventory. This places ECS Botanics Holdings in the lower half of its industry. The industry median Days Inventory is 164.43. ECS Botanics Holdings' value of 377.71 is 129.7% above this benchmark. Historically, ECS Botanics Holdings' own Days Inventory has ranged from 275.12 to 614.10 over the past decade. While the company's 10-year median is 422.51 vs. the industry median of 164.43, ECS Botanics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ECS Botanics Holdings's current Days Inventory of 377.71 is 129.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ECS Botanics Holdings and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ECS Botanics Holdings's current Days Inventory is 377.71, which is 11% below median its own 10-year median of 422.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ECS Botanics Holdings stock overvalued right now?
Based on GuruFocus' analysis, ECS Botanics Holdings (ASX:ECS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 80% below its estimated fair value. The current Days Inventory is 377.71, which is 11% below median its 10-year median of 422.51 and 129.7% above the Drug Manufacturers industry median of 164.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For ECS Botanics Holdings (ASX:ECS), the current Days Inventory is 377.71 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ECS Botanics Holdings Ltd is an Australian medicinal cannabis cultivator and manufacturer located in Northwest Victoria. The company utilizes progressive cultivation methodologies to produce quality medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. Licensed by the Therapeutic Drug Administration to manufacture PIC/S GMP certified products, the company provides quality, affordable medicinal cannabis, supplying both local and overseas markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ECS has been successfully added to your 